China Pharma Holdings
CPHI
9 hedge funds and large institutions have $1.41M invested in China Pharma Holdings in 2013 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 0 closing their positions.
29% more funds holding
Funds holding: 7 → 9 (+2)
19% more capital invested
Capital invested by funds: $1.18M → $1.41M (+$224K)
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$14.8K |
| 2 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
+$2.86K |
| 3 |
Morgan Stanley
New York
|
+$505 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FWSM
First Wilshire Securities Management
Pasadena,
California
|
-$20.9K |
| 2 |
PAM
Pope Asset Management
Memphis,
Tennessee
|
-$8.09K |
| 3 |
Renaissance Technologies
New York
|
-$6.4K |
| 4 |
CAM
Carret Asset Management
New York
|
-$5.05K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$4.04K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
1
Pope Asset Management
Memphis,
Tennessee
| $740K | -$8.09K | -48 | -1% |
|
|
FWSM
2
First Wilshire Securities Management
Pasadena,
California
| $511K | -$20.9K | -124 | -4% |
|
|
GA
3
Glenhill Advisors
New York
| $69K | – | – | – |
|
|
4
Renaissance Technologies
New York
| $53K | -$6.4K | -38 | -11% |
|
|
5
Citadel Advisors
Miami,
Florida
| $15K | +$14.8K | +88 | New |
|
|
CAM
6
Carret Asset Management
New York
| $10K | -$5.05K | -30 | -33% |
|
|
VKH
7
Virtu KCG Holdings
New York
| $4K | -$4.04K | -24 | -50% |
|
|
PFO
8
Pathstone Family Office
Englewood,
New Jersey
| $3K | +$2.86K | +17 | New |
|
|
9
Morgan Stanley
New York
| – | +$505 | +3 | New |
|
CPHI Hedge Fund Activity: Q4 2013 in Review
9 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q4 2013, worth a combined $1.41M — up 19% from $1.18M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CPHI positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 5 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $14.8K. The largest seller was First Wilshire Securities Management, cutting an estimated $20.9K.
- 9 institutional investors held China Pharma Holdings (CPHI) as of Q4 2013, up from 7 in Q3 2013.
- Funds reported $1.41M of China Pharma Holdings stock for Q4 2013, up 19% quarter-over-quarter.
- 3 funds opened new China Pharma Holdings positions in Q4 2013 and 0 closed out, a net change of +3 holders.
- The largest China Pharma Holdings buyer in Q4 2013 was Citadel Advisors, an estimated $14.8K added.
- The largest China Pharma Holdings seller in Q4 2013 was First Wilshire Securities Management, an estimated $20.9K sold.
Based on aggregated 13F filings for Q4 2013.